Condensed Consolidated Statements of Stockholders’ Deficit (unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Treasury Stock	Total
Balance at Dec. 31, 2023	$ 541	$ 88,402,738	$ (66,272,382)	$ (12,045,542)	$ 10,085,355
Balance (in Shares) at Dec. 31, 2023	540,906
Stock-based compensation		656,576			656,576
Stock grant program vesting	$ 10	(10)
Stock grant program vesting (in Shares)	9,837
Net loss			(2,560,563)		(2,560,563)
Balance at Mar. 31, 2024	$ 551	89,059,304	(68,832,945)	(12,045,542)	8,181,368
Balance (in Shares) at Mar. 31, 2024	550,743
Balance at Dec. 31, 2023	$ 541	88,402,738	(66,272,382)	(12,045,542)	10,085,355
Balance (in Shares) at Dec. 31, 2023	540,906
Net loss					(9,283,099)
Balance at Sep. 30, 2024	$ 563	89,993,096	(75,555,481)	(12,045,542)	2,392,636
Balance (in Shares) at Sep. 30, 2024	562,534
Balance at Mar. 31, 2024	$ 551	89,059,304	(68,832,945)	(12,045,542)	8,181,368
Balance (in Shares) at Mar. 31, 2024	550,743
Stock-based compensation		460,785			460,785
Stock grant program vesting	$ 7	(7)
Stock grant program vesting (in Shares)	6,902
Stock issued for contingent consideration	$ 3	129,132			129,135
Stock issued for contingent consideration (in Shares)	2,848
Net loss			(2,964,728)		(2,964,728)
Balance at Jun. 30, 2024	$ 561	89,649,214	(71,797,673)	(12,045,542)	5,806,560
Balance (in Shares) at Jun. 30, 2024	560,493
Stock-based compensation		343,884			343,884
Stock grant program vesting	$ 2	(2)
Stock grant program vesting (in Shares)	2,041
Net loss			(3,757,808)		(3,757,808)
Balance at Sep. 30, 2024	$ 563	89,993,096	(75,555,481)	(12,045,542)	2,392,636
Balance (in Shares) at Sep. 30, 2024	562,534
Balance at Dec. 31, 2024	$ 563	90,170,645	(102,768,208)	(12,045,542)	(24,642,542)
Balance (in Shares) at Dec. 31, 2024	562,855
Stock-based compensation	$ 3	324,268			324,271
Stock-based compensation (in Shares)	3,000
Stock grant program vesting	$ 11	(11)
Stock grant program vesting (in Shares)	10,559
Issuance of common stock for loan modification	$ 6	109,418			109,424
Issuance of common stock for loan modification (in Shares)	6,000
Net loss			(4,033,912)		(4,033,912)
Balance at Mar. 31, 2025	$ 583	90,604,320	(106,802,120)	(12,045,542)	(28,242,759)
Balance (in Shares) at Mar. 31, 2025	582,414
Balance at Dec. 31, 2024	$ 563	90,170,645	(102,768,208)	(12,045,542)	(24,642,542)
Balance (in Shares) at Dec. 31, 2024	562,855
Net loss					(15,077,910)
Balance at Sep. 30, 2025	$ 588	90,984,530	(117,846,118)	(12,045,542)	(38,906,542)
Balance (in Shares) at Sep. 30, 2025	587,598
Balance at Mar. 31, 2025	$ 583	90,604,320	(106,802,120)	(12,045,542)	(28,242,759)
Balance (in Shares) at Mar. 31, 2025	582,414
Stock-based compensation		210,193			210,193
Stock grant program vesting	$ 5	(5)
Stock grant program vesting (in Shares)	4,864
Net loss			(6,204,144)		(6,204,144)
Balance at Jun. 30, 2025	$ 588	90,814,508	(113,006,264)	(12,045,542)	(34,236,710)
Balance (in Shares) at Jun. 30, 2025	587,278
Stock-based compensation		170,022			170,022
Stock grant program vesting
Stock grant program vesting (in Shares)	320
Net loss			(4,839,854)		(4,839,854)
Balance at Sep. 30, 2025	$ 588	$ 90,984,530	$ (117,846,118)	$ (12,045,542)	$ (38,906,542)
Balance (in Shares) at Sep. 30, 2025	587,598

urban-gro, Inc. 10-Q